abstract |
the present invention features compositions of aip peptides and polynucleotides, methods of using such compositions for the treatment of cpvt, as well as a model of cardiomyocytes derived from human-induced pluripotent stem cells, useful in characterizing agents that modulate conduction and contraction of the myocardium. |